Pedone Chiara, Elhendy Abdou, van Domburg Ron T, Nelwan Stefan P, Biagini Elena, Di Pasquale Giuseppe, Bax Jeroen J, Poldermans Don
Department of Cardiology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Coron Artery Dis. 2011 Dec;22(8):559-64. doi: 10.1097/MCA.0b013e32834c74da.
The aim of this study was to determine whether resting ST-T wave abnormalities (ST-Ta) provide incremental prognostic information in patients with no history of coronary artery disease undergoing dobutamine stress echocardiography (DSE).
We evaluated 1308 consecutive patients without previous myocardial infarction (MI) or revascularization who underwent DSE. Ischemia was defined as new or worsening wall motion abnormalities. End points during follow-up were all-cause death and cardiac death/nonfatal MI.
ST-Ta were detected in 162 (12%) patients. The incidence of ischemia was higher in patients with baseline ST-Ta than patients without [74 (46%) vs. 327 (28%), P=0.00001]. During a follow-up of 4.6 ± 3 years, cardiac death/nonfatal MI occurred in 42 (26%) patients with resting ST-Ta and in 157 (14%) patients without resting ST-Ta (P<0.001). Patients with ST-Ta had a higher annual cardiac death/nonfatal MI rate compared with patients without, both in the presence of normal DSE (3.2 vs. 1.4%, P=0.01) as well as abnormal DSE (5.3 vs. 3%, P<0.001). In a Cox proportional modeling, resting ST-Ta added incremental value over clinical and stress echocardiographic data for the prediction of death (global χ 125, 140, 150, respectively; P<0.05) and cardiac death/nonfatal MI (global χ 79, 100, 111, respectively; P<0.05).
Baseline ST-Ta are associated with an increased risk of cardiac death/nonfatal MI and all-cause mortality, incremental to clinical data and DSE results. The associated risk is persistent among patients with normal DSE.
本研究旨在确定静息ST-T波异常(ST-Ta)是否能为无冠心病病史且接受多巴酚丁胺负荷超声心动图(DSE)检查的患者提供额外的预后信息。
我们评估了1308例连续接受DSE检查且既往无心肌梗死(MI)或血运重建史的患者。缺血定义为新出现或加重的室壁运动异常。随访终点为全因死亡和心源性死亡/非致死性MI。
162例(12%)患者检测到ST-Ta。基线存在ST-Ta的患者缺血发生率高于无ST-Ta的患者[74例(46%)对327例(28%),P = 0.00001]。在4.6±3年的随访期间,静息ST-Ta的患者中心源性死亡/非致死性MI发生42例(26%),无静息ST-Ta的患者中发生157例(14%)(P<0.001)。无论DSE结果正常(3.2%对1.4%,P = 0.01)还是异常(5.3%对3%,P<0.001),有ST-Ta的患者年度心源性死亡/非致死性MI发生率均高于无ST-Ta的患者。在Cox比例模型中,静息ST-Ta在预测死亡(总体χ分别为125、140、150;P<0.05)和心源性死亡/非致死性MI(总体χ分别为79、100、111;P<0.05)方面,在临床和负荷超声心动图数据基础上增加了额外价值。
基线ST-Ta与心源性死亡/非致死性MI风险增加及全因死亡率增加相关,这是在临床数据和DSE结果基础上的额外风险。在DSE结果正常的患者中,相关风险持续存在。